发明名称 |
4-SUBSTITUTED BETA-CARBOLINES AS IMMUNOMODULATORS |
摘要 |
This invention relates to 4-substituted .beta.-carbolines and .beta.-carboline analogs that inhibit Ca+2 influx and interleukin-2 (IL-2) production. The 4substituted .beta.-carbolines and .beta.-carboline analogs of this invention are represented by formula (I) wherein Q, n, R, R', R'' and R1-R4 are as defined herein. This invention also relates to methods for producing .beta.carbolines. Because of their selective immunomodulating properties, the compounds and pharmaceutical compositions of this invention are particularly well suited for preventing and treating immune disorders, including autoimmune disease, inflammatory disease, organ transplant rejection and other disorders associated with IL-2 mediated immune response.
|
申请公布号 |
CA2262796(A1) |
申请公布日期 |
1998.02.19 |
申请号 |
CA19972262796 |
申请日期 |
1997.08.08 |
申请人 |
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. |
发明人 |
HARGRAVE, KARL D.;SNOW, ROGER J.;PARKS, THOMAS P.;POTOCKI, IAN F.;MIAO, CLARA K. |
分类号 |
C07D491/048;A61K31/4355;A61K31/4365;A61K31/437;A61K31/444;A61P37/02;C07D471/04;C07D495/04;(IPC1-7):C07D471/04;C07F7/10;A61K31/435;A61K31/495;A61K31/535;A61K31/54;A61K31/55;A61K31/695 |
主分类号 |
C07D491/048 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|